Heritage Family Offices LLP Has $985,000 Stock Holdings in McKesson Co. (NYSE:MCK)

Heritage Family Offices LLP reduced its position in McKesson Co. (NYSE:MCK - Free Report) by 42.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,729 shares of the company's stock after selling 1,283 shares during the period. Heritage Family Offices LLP's holdings in McKesson were worth $985,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in MCK. International Assets Investment Management LLC grew its position in McKesson by 1,020.2% during the 3rd quarter. International Assets Investment Management LLC now owns 806,878 shares of the company's stock worth $398,937,000 after purchasing an additional 734,849 shares in the last quarter. FMR LLC grew its holdings in shares of McKesson by 17.3% during the third quarter. FMR LLC now owns 2,968,239 shares of the company's stock valued at $1,467,557,000 after buying an additional 438,423 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in McKesson by 55.8% during the third quarter. The Manufacturers Life Insurance Company now owns 1,189,377 shares of the company's stock valued at $588,048,000 after buying an additional 425,875 shares during the period. Janus Henderson Group PLC lifted its stake in McKesson by 126.8% in the 3rd quarter. Janus Henderson Group PLC now owns 574,440 shares of the company's stock worth $283,903,000 after acquiring an additional 321,119 shares in the last quarter. Finally, Nordea Investment Management AB boosted its position in McKesson by 20.0% during the 4th quarter. Nordea Investment Management AB now owns 975,935 shares of the company's stock worth $558,606,000 after acquiring an additional 162,688 shares during the period. Institutional investors and hedge funds own 85.07% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on MCK shares. Bank of America dropped their target price on McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a report on Monday, January 6th. StockNews.com raised shares of McKesson from a "hold" rating to a "buy" rating in a research report on Wednesday, November 6th. Leerink Partners lowered their price objective on shares of McKesson from $665.00 to $630.00 and set an "outperform" rating on the stock in a research report on Monday, October 7th. Baird R W raised shares of McKesson from a "hold" rating to a "strong-buy" rating in a research report on Thursday, November 7th. Finally, Citigroup lowered their price objective on shares of McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a research report on Friday, January 10th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $646.14.

Insider Activity at McKesson

In related news, EVP Leann B. Smith sold 579 shares of the company's stock in a transaction on Monday, December 9th. The shares were sold at an average price of $602.81, for a total transaction of $349,026.99. Following the completion of the transaction, the executive vice president now directly owns 1,443 shares in the company, valued at $869,854.83. This represents a 28.64 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.11% of the company's stock.

McKesson Stock Performance

Shares of McKesson stock traded up $11.17 on Thursday, reaching $594.62. The stock had a trading volume of 582,348 shares, compared to its average volume of 644,495. The business's 50-day moving average price is $595.77 and its two-hundred day moving average price is $561.06. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $637.51. The stock has a market cap of $75.48 billion, a P/E ratio of 30.79, a price-to-earnings-growth ratio of 1.26 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, topping analysts' consensus estimates of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The business had revenue of $93.65 billion during the quarter, compared to analysts' expectations of $89.33 billion. During the same period in the previous year, the company earned $6.23 earnings per share. McKesson's revenue for the quarter was up 21.3% on a year-over-year basis. As a group, equities analysts forecast that McKesson Co. will post 32.73 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Monday, December 2nd were paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.48%. The ex-dividend date was Monday, December 2nd. McKesson's payout ratio is currently 14.71%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.